Nine-Year Follow-Up of Interleukin 6 in Chronic Obstructive Pulmonary Disease – Complementary Results from Previous Studies
Robson Prudente,1 Renata Ferrari,2 Carolina Mesquita,2 Luiz Machado,2 Estefânia Franco,1 Irma Godoy,2 Suzana Tanni2 1Clinical Hospital of Botucatu Medical School, Department of Internal Medicine, Pneumology Area, Botucatu School of Medicine, São Paulo State University (UNESP), Botucatu, São Paulo, B...
Saved in:
Main Authors: | Prudente R, Ferrari R, Mesquita C, Machado L, Franco E, Godoy I, Tanni S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d0011968a77a43b0a92278e6e8d835d3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Small Cell Lung Cancer
by: Liao KM, et al.
Published: (2021) -
The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea
by: Lu Yan, et al.
Published: (2021) -
Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study
by: Chun-Mei Feng, et al.
Published: (2021) -
Right Atrium Volume Index in Non-Severe Chronic Obstructive Pulmonary Disease
by: Cherneva Zh., et al.
Published: (2020) -
Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
by: Choi JH, et al.
Published: (2021)